The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.
Aryanna LeBron, PharmD
Advertisement
Aryanna LeBron is a 2025 PharmD candidate at the University of Connecticut School of Pharmacy, in Storrs, Connecticut.
Articles by Aryanna LeBron, PharmD
Advertisement
Latest Updated Articles
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in InfantsPublished: October 21st 2025 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
2
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
3
Q&A: TrumpRx Could Change the Way Pharmacies, PBMs Do Business
4
New Research Highlights Dietary Interventions to Potentially Manage Asthma
5
